{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:17:42Z","timestamp":1792631862864,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T00:00:00Z","timestamp":1502668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11914-017-0394-8","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T08:44:03Z","timestamp":1502700243000},"page":"443-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Vitamin D Activity and Metabolism in Bone"],"prefix":"10.1007","volume":"15","author":[{"given":"Paul H.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,14]]},"reference":[{"issue":"1","key":"394_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1445-5994.2000.tb01049.x","volume":"30","author":"JA Pasco","year":"2000","unstructured":"Pasco JA, Sanders KM, Henry MJ, Nicholson GC, Seeman E, Kotowicz MA. Calcium intakes among Australian women: Geelong osteoporosis study. Aust NZ J Med. 2000;30(1):21\u20137.","journal-title":"Aust NZ J Med"},{"issue":"9588","key":"394_CR2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)61342-7","volume":"370","author":"BM Tang","year":"2007","unstructured":"Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370(9588):657\u201366.","journal-title":"Lancet"},{"key":"394_CR3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2458-10-331","volume":"10","author":"JKC Lai","year":"2010","unstructured":"Lai JKC, Lucas RM, Clements MS, Roddam AW, Banks E. Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health. 2010;10:331.","journal-title":"BMC Public Health"},{"key":"394_CR4","doi-asserted-by":"crossref","unstructured":"Pike JW, Meyer MB, Lee SM, Onal M, Benkusky NA. The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights. J Clin Invest. 2017.","DOI":"10.1172\/JCI88887"},{"issue":"1\u20132","key":"394_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2007.12.018","volume":"285","author":"PH Anderson","year":"2008","unstructured":"Anderson PH, Hendrix I, Sawyer RK, Zarrinkalam R, Manavis J, Sarvestani GT, et al. Co-expression of CYP27B1 enzyme with the 1.5 kb CYP27B1 promoter-luciferase transgene in the mouse. Mol Cell Endocrinol. 2008;285(1\u20132):1\u20139.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"394_CR6","first-page":"888","volume":"86","author":"D Zehnder","year":"2001","unstructured":"Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86(2):888\u201394.","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"394_CR7","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1073\/pnas.94.18.9831","volume":"94","author":"YC Li","year":"1997","unstructured":"Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A. 1997;94(18):9831\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"394_CR8","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1210\/endo.142.7.8281","volume":"142","author":"O Dardenne","year":"2001","unstructured":"Dardenne O, Prud'homme J, Arabian A, Glorieux FH, St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology. 2001;142(7):3135\u201341.","journal-title":"Endocrinology"},{"issue":"7","key":"394_CR9","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1210\/mend.16.7.0866","volume":"16","author":"RG Erben","year":"2002","unstructured":"Erben RG, Soegiarto DW, Weber K, Zeitz U, Lieberherr M, Gniadecki R, et al. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol. 2002;16(7):1524\u201337.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"394_CR10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S8756-3282(03)00023-1","volume":"32","author":"O Dardenne","year":"2003","unstructured":"Dardenne O, Prud'homme J, Hacking SA, Glorieux FH, St-Arnaud R. Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). Bone. 2003;32(4):332\u201340.","journal-title":"Bone"},{"issue":"11","key":"394_CR11","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1210\/endo.140.11.7110","volume":"140","author":"M Amling","year":"1999","unstructured":"Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, et al. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology. 1999;140(11):4982\u20137.","journal-title":"Endocrinology"},{"issue":"16","key":"394_CR12","doi-asserted-by":"crossref","first-page":"16754","DOI":"10.1074\/jbc.M310271200","volume":"279","author":"DK Panda","year":"2004","unstructured":"Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, et al. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem. 2004;279(16):16754\u201366.","journal-title":"J Biol Chem"},{"key":"394_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jsbmb.2015.12.005","volume":"164","author":"JW Ryan","year":"2015","unstructured":"Ryan JW, Starczak Y, Tsangari H, Sawyer RK, Davey RA, Atkins GJ, et al. Sex-related differences in the skeletal phenotype of aged vitamin D receptor global knockout mice. J Steroid Biochem Mol Biol. 2015;164:361\u20138.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"394_CR14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/en.2012-1542","volume":"154","author":"Y Yamamoto","year":"2013","unstructured":"Yamamoto Y, Yoshizawa T, Fukuda T, Shirode-Fukuda Y, Yu T, Sekine K, et al. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology. 2013;154(3):1008\u201320.","journal-title":"Endocrinology"},{"issue":"6","key":"394_CR15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/jbmr.3096","volume":"32","author":"Y Nakamichi","year":"2017","unstructured":"Nakamichi Y, Udagawa N, Horibe K, Mizoguchi T, Yamamoto Y, Nakamura T, et al. VDR in osteoblast-lineage cells primarily mediates vitamin D treatment-induced increase in bone mass by suppressing bone resorption. J Bone Miner Res. 2017;32(6):1297\u2013308.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"394_CR16","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1172\/JCI45890","volume":"122","author":"L Lieben","year":"2012","unstructured":"\u2022\u2022 Lieben L, Masuyama R, Torrekens S, Van Looveren R, Schrooten J, Baatsen P, et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest. 2012;122(5):1803\u201315. This paper describes the relative importance of VDR-mediated siganlling in osteocytes in the process of regulating mineralisation. Data presented here illustrate that that bone mineralisation is a co-ordinated process which can be inhibited by excessive vitamin D activity.","journal-title":"J Clin Invest"},{"issue":"6","key":"394_CR17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1359\/jbmr.2003.18.6.1088","volume":"18","author":"GJ Atkins","year":"2003","unstructured":"Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, et al. RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res. 2003;18(6):1088\u201398.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"394_CR18","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1210\/endo-128-3-1496","volume":"128","author":"TA Owen","year":"1991","unstructured":"Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology. 1991;128(3):1496\u2013504.","journal-title":"Endocrinology"},{"issue":"5","key":"394_CR19","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jbmr.298","volume":"26","author":"S Geng","year":"2011","unstructured":"\u2022\u2022 Geng S, Zhou S, Glowacki J. Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1\/1alpha-hydroxylase. J Bone Miner Res. 2011;26(5):1145\u201353. This papers contributes important evidence tht local synthesis of vitamin D within osteoblasts-lineage cells plays a key role on the promotion of osteoblastogenesis.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"394_CR20","doi-asserted-by":"crossref","first-page":"140201","DOI":"10.1098\/rsob.140201","volume":"5","author":"H Kato","year":"2015","unstructured":"Kato H, Ochiai-Shino H, Onodera S, Saito A, Shibahara T, Azuma T. Promoting effect of 1,25(OH)2 vitamin D3 in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells. Open Biol. 2015;5(2):140201.","journal-title":"Open Biol"},{"issue":"10","key":"394_CR21","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1210\/en.2006-0403","volume":"147","author":"Y Xue","year":"2006","unstructured":"Xue Y, Karaplis AC, Hendy GN, Goltzman D, Miao D. Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles. Endocrinology. 2006;147(10):4801\u201310.","journal-title":"Endocrinology"},{"issue":"6","key":"394_CR22","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bone.2007.02.024","volume":"40","author":"GJ Atkins","year":"2007","unstructured":"Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, et al. Metabolism of vitamin D(3) in human osteoblasts: evidence for autocrine and paracrine activities of 1alpha,25-dihydroxyvitamin D(3). Bone. 2007;40(6):1517\u201328.","journal-title":"Bone"},{"key":"394_CR23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mce.2015.06.005","volume":"412","author":"D Yang","year":"2015","unstructured":"Yang D, Turner AG, Wijenayaka AR, Anderson PH, Morris HA, Atkins GJ. 1,25-Dihydroxyvitamin D3 and extracellular calcium promote mineral deposition via NPP1 activity in a mature osteoblast cell line MLO-A5. Mol Cell Endocrinol. 2015;412:140\u20137.","journal-title":"Mol Cell Endocrinol"},{"key":"394_CR24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jsbmb.2012.11.016","volume":"136","author":"D Yang","year":"2013","unstructured":"Yang D, Atkins GJ, Turner AG, Anderson PH, Morris HA. Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like cultures. J Steroid Biochem Mol Biol. 2013;136:166\u201370.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"394_CR25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bone.2012.07.014","volume":"51","author":"NC Mackenzie","year":"2012","unstructured":"Mackenzie NC, Huesa C, Rutsch F, MacRae VE. New insights into NPP1 function: lessons from clinical and animal studies. Bone. 2012;51(5):961\u20138.","journal-title":"Bone"},{"issue":"13","key":"394_CR26","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1096\/fj.99-1075com","volume":"14","author":"EM Gardiner","year":"2000","unstructured":"Gardiner EM, Baldock PA, Thomas GP, Sims NA, Henderson NK, Hollis B, et al. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J. 2000;14(13):1908\u201316.","journal-title":"FASEB J"},{"key":"394_CR27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jsbmb.2015.08.009","volume":"164","author":"R Triliana","year":"2016","unstructured":"Triliana R, Lam NN, Sawyer RK, Atkins GJ, Morris HA, Anderson PH. Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model. J Steroid Biochem Mol Biol. 2016;164:331\u20136.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"394_CR28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jsbmb.2014.01.002","volume":"144","author":"NN Lam","year":"2014","unstructured":"Lam NN, Triliana R, Sawyer RK, Atkins GJ, Morris HA, O'Loughlin PD, et al. Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency. J Steroid Biochem Mol Biol. 2014;144:128\u201331.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"394_CR29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.mam.2008.05.003","volume":"29","author":"PH Anderson","year":"2008","unstructured":"Anderson PH, Atkins GJ. The skeleton as an intracrine organ for vitamin D metabolism. Mol Asp Med. 2008;29(6):397\u2013406.","journal-title":"Mol Asp Med"},{"issue":"13","key":"394_CR30","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1096\/fj.06-6374fje","volume":"20","author":"M Driel van","year":"2006","unstructured":"van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, et al. Evidence for auto\/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J. 2006;20(13):2417\u20139.","journal-title":"FASEB J"},{"key":"394_CR31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jsbmb.2013.10.003","volume":"144","author":"AG Turner","year":"2014","unstructured":"Turner AG, Hanrath MA, Morris HA, Atkins GJ, Anderson PH. The local production of 1, 25 (OH) 2 D 3 promotes osteoblast and osteocyte maturation. J Steroid Biochem Mol Biol. 2014;144:114\u20138.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3\u20135","key":"394_CR32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jsbmb.2006.12.084","volume":"103","author":"PH Anderson","year":"2007","unstructured":"Anderson PH, Atkins GJ, Findlay DM, Oloughlin PD, Welldon K, Vincent C, et al. RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. J Steroid Biochem Mol Biol. 2007;103(3\u20135):601\u20135.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"394_CR33","unstructured":"Turner AG, RK Sawyer, O\u2019Loughlin PD, Atkins GJ, Morris HA, Anderson PH. Transgene expression of CYP27B1 in osteoblasts promotes bone formation without altering bone resorption. J Bone Miner Res. 2012;27(Suppl 1). Available at: http:\/\/www.asbmr.org\/education\/AbstractDetail?aid=05ac9f70-6487-4091-b38f-49cd239a7a29 ."},{"issue":"16","key":"394_CR34","doi-asserted-by":"crossref","first-page":"16754","DOI":"10.1074\/jbc.M310271200","volume":"279","author":"DK Panda","year":"2004","unstructured":"Panda DK, Miao DS, Bolivar I, Li JR, Huo RJ, Hendy GN, et al. Inactivation of the 25-hydroxyvitamin D 1 alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem. 2004;279(16):16754\u201366.","journal-title":"J Biol Chem"},{"issue":"11","key":"394_CR35","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1359\/jbmr.080616","volume":"23","author":"PH Anderson","year":"2008","unstructured":"Anderson PH, Sawyer RK, Moore AJ, May BK, O'Loughlin PD, Morris HA. Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res. 2008;23(11):1789\u201397.","journal-title":"J Bone Miner Res"},{"issue":"1\u20132","key":"394_CR36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jsbmb.2010.04.004","volume":"121","author":"AM Lee","year":"2010","unstructured":"Lee AM, Anderson PH, Sawyer RK, Moore AJ, Forwood MR, Steck R, et al. Discordant effects of vitamin D deficiency in trabecular and cortical bone architecture and strength in growing rodents. J Steroid Biochem Mol Biol. 2010;121(1\u20132):284\u20137.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"394_CR37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jsbmb.2013.11.009","volume":"144","author":"AM Lee","year":"2013","unstructured":"Lee AM, Sawyer RK, Moore AJ, Morris HA, O'Loughlin PD, Anderson PH. Adequate dietary vitamin D and calcium are both required to reduce bone turnover and increased bone mineral volume. J Steroid Biochem Mol Biol. 2013;144:159\u201362.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"394_CR38","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jsbmb.2006.12.086","volume":"103","author":"P Anderson","year":"2007","unstructured":"Anderson P, Sawyer R, May B, O\u2019Loughlin P, Morris H. 25-Hydroxyvitamin D requirement for maintaining skeletal health utilising a Sprague-Dawley rat model. J Steroid Biochem Mol Biol. 2007;103(3):592\u20135.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3\u20135","key":"394_CR39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jsbmb.2006.12.086","volume":"103","author":"PH Anderson","year":"2007","unstructured":"Anderson PH, Sawyer RK, May BK, O'Loughlin PD, Morris HA. 25-Hydroxyvitamin D requirement for maintaining skeletal health utilising a Sprague-Dawley rat model. J Steroid Biochem Mol Biol. 2007;103(3\u20135):592\u20135.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"394_CR40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF00308324","volume":"52","author":"C Lidor","year":"1993","unstructured":"Lidor C, Sagiv P, Amdur B, Gepstein R, Otremski I, Hallel T, et al. Decrease in bone levels of 1,25-dihydroxyvitamin D in women with subcapital fracture of the femur. Calcif Tissue Int. 1993;52(2):146\u20138.","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"394_CR41","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/en.2004-1116","volume":"146","author":"S Masuda","year":"2005","unstructured":"Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, et al. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology. 2005;146(2):825\u201334.","journal-title":"Endocrinology"},{"issue":"2","key":"394_CR42","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2013.02.3188","volume":"190","author":"D Dinour","year":"2013","unstructured":"Dinour D, Beckerman P, Ganon L, Tordjman K, Eisenstein Z, Holtzman EJ. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis. J Urol. 2013;190(2):552\u20137.","journal-title":"J Urol"},{"key":"394_CR43","doi-asserted-by":"crossref","unstructured":"Sumantran VN, Mishra P, Bera R, Sudhakar N. Microarray analysis of differentially-expressed genes encoding CYP450 and phase II drug metabolizing enzymes in psoriasis and melanoma. Pharmaceutics. 2016;8(1).","DOI":"10.3390\/pharmaceutics8010004"},{"issue":"2","key":"394_CR44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbalip.2006.01.004","volume":"1761","author":"S Masuda","year":"2006","unstructured":"Masuda S, Strugnell SA, Knutson JC, St-Arnaud R, Jones G. Evidence for the activation of 1alpha-hydroxyvitamin D2 by 25-hydroxyvitamin D-24-hydroxylase: delineation of pathways involving 1alpha,24-dihydroxyvitamin D2 and 1alpha,25-dihydroxyvitamin D2. Biochim Biophys Acta. 2006;1761(2):221\u201334.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"394_CR45","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.yexcr.2012.02.027","volume":"318","author":"LD Quarles","year":"2012","unstructured":"Quarles LD. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp Cell Res. 2012;318(9):1040\u20138.","journal-title":"Exp Cell Res"},{"issue":"8","key":"394_CR46","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1210\/endo.139.8.6134","volume":"139","author":"HJ Armbrecht","year":"1998","unstructured":"Armbrecht HJ, Hodam TL, Boltz MA, Partridge NC, Brown AJ, Kumar VB. Induction of the vitamin D 24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 is regulated by parathyroid hormone in UMR106 osteoblastic cells. Endocrinology. 1998;139(8):3375\u201381.","journal-title":"Endocrinology"},{"key":"394_CR47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jsbmb.2012.09.029","volume":"136","author":"N Ito","year":"2013","unstructured":"Ito N, Findlay DM, Anderson PH, Bonewald LF, Atkins GJ. Extracellular phosphate modulates the effect of 1 alpha,25-dihydroxy vitamin D-3 (1,25D) on osteocyte like cells. J Steroid Biochem Mol Biol. 2013;136:183\u20136.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1\u20132","key":"394_CR48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mce.2011.05.018","volume":"347","author":"R St-Arnaud","year":"2011","unstructured":"St-Arnaud R, Naja RP. Vitamin D metabolism, cartilage and bone fracture repair. Mol Cell Endocrinol. 2011;347(1\u20132):48\u201354.","journal-title":"Mol Cell Endocrinol"},{"issue":"1\u20132","key":"394_CR49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2010.03.048","volume":"121","author":"M Kogawa","year":"2010","unstructured":"Kogawa M, Anderson PH, Findlay DM, Morris HA, Atkins GJ. The metabolism of 25-(OH)vitamin D-3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. J Steroid Biochem Mol Biol. 2010;121(1\u20132):277\u201380.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"7","key":"394_CR50","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1210\/endo.141.7.7579","volume":"141","author":"R St-Arnaud","year":"2000","unstructured":"St-Arnaud R, Arabian A, Travers R, Barletta F, Raval-Pandya M, Chapin K, et al. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology. 2000;141(7):2658\u201366.","journal-title":"Endocrinology"},{"key":"394_CR51","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/en.2004-1116","volume":"146","author":"S Masuda","year":"2005","unstructured":"Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, et al. Altered pharmacokinetics of 1a,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology. 2005;146:825\u201334.","journal-title":"Endocrinology"},{"issue":"6","key":"394_CR52","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1096\/fj.02-0965fje","volume":"17","author":"N Hosogane","year":"2003","unstructured":"Hosogane N, Shinki T, Kasuga H, Taketomi S, Toyama Y, Suda T. Mechanisms for the reduction of 24,25-dihydroxyvitamin D3 levels and bone mass in 24-hydroxylase transgenic rats. FASEB J. 2003;17(6):737\u20139.","journal-title":"FASEB J"},{"issue":"5","key":"394_CR53","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0006-291X(02)02254-4","volume":"297","author":"H Kasuga","year":"2002","unstructured":"Kasuga H, Hosogane N, Matsuoka K, Mori I, Sakura Y, Shimakawa K, et al. Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. Biochem Biophys Res Commun. 2002;297(5):1332\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"394_CR54","first-page":"839","volume":"76","author":"NE Friedman","year":"1993","unstructured":"Friedman NE, Lobaugh B, Drezner MK. Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia. J Clin Endocrinol Metab. 1993;76(4):839\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"394_CR55","doi-asserted-by":"crossref","unstructured":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet. 1995;11(2):130\u20136.","DOI":"10.1038\/ng1095-130"},{"issue":"1","key":"394_CR56","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","volume":"291","author":"S Liu","year":"2006","unstructured":"Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab. 2006;291(1):E38\u201349.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"24","key":"394_CR57","doi-asserted-by":"crossref","first-page":"18270","DOI":"10.1074\/jbc.M109.098616","volume":"285","author":"SU Miedlich","year":"2010","unstructured":"Miedlich SU, Zalutskaya A, Zhu ED, Demay MB. Phosphate-induced apoptosis of hypertrophic chondrocytes is associated with a decrease in mitochondrial membrane potential and is dependent upon Erk1\/2 phosphorylation. J Biol Chem. 2010;285(24):18270\u20135.","journal-title":"J Biol Chem"},{"issue":"27","key":"394_CR58","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.0502249102","volume":"102","author":"Y Sabbagh","year":"2005","unstructured":"Sabbagh Y, Carpenter TO, Demay MB. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci U S A. 2005;102(27):9637\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"394_CR59","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI81928","volume":"126","author":"X Bai","year":"2016","unstructured":"\u2022\u2022 Bai X, Miao D, Xiao S, Qiu D, St-Arnaud R, Petkovich M, et al. CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders. J Clin Invest. 2016;126(2):667\u201380. This paper describes desmostrates that CYP24A1 inhibtion can prevent rickets without the need to restore circulating phosphate or calcitriol levels in the disorder of x-linked hypophosphatemia.","journal-title":"J Clin Invest"},{"issue":"3","key":"394_CR60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<390::AID-JCP10>3.0.CO;2-T","volume":"182","author":"Z Schwartz","year":"2000","unstructured":"Schwartz Z, Sylvia VL, Del Toro F, Hardin RR, Dean DD, Boyan BD. 24R,25-(OH)(2)D(3) mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase a(2) and cyclooxygenase-1 but not cyclooxygenase-2 in growth plate chondrocytes. J Cell Physiol. 2000;182(3):390\u2013401.","journal-title":"J Cell Physiol"},{"issue":"5","key":"394_CR61","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bbamcr.2009.01.020","volume":"1793","author":"J Hurst-Kennedy","year":"2009","unstructured":"Hurst-Kennedy J, Boyan BD, Schwartz Z. Lysophosphatidic acid signaling promotes proliferation, differentiation, and cell survival in rat growth plate chondrocytes. Biochim Biophys Acta. 2009;1793(5):836\u201346.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"394_CR62","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1359\/jbmr.1997.12.4.598","volume":"12","author":"EG Seo","year":"1997","unstructured":"Seo EG, Norman AW. Three-fold induction of renal 25-hydroxyvitamin D3-24-hydroxylase activity and increased serum 24,25-dihydroxyvitamin D3 levels are correlated with the healing process after chick tibial fracture. J Bone Miner Res. 1997;12(4):598\u2013606.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"394_CR63","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1210\/endo.138.9.5398","volume":"138","author":"EG Seo","year":"1997","unstructured":"Seo EG, Einhorn TA, Norman AW. 24R,25-dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology. 1997;138(9):3864\u201372.","journal-title":"Endocrinology"},{"key":"394_CR64","doi-asserted-by":"publisher","unstructured":"Husseini A, St-Arnaud R. CYP24A1-deficiency does not affect bone regeneration in distraction osteogenesis. J Steroid Biochem Mol Biol. 2016; doi: 10.1016\/j.jsbmb.2016.11.003 .","DOI":"10.1016\/j.jsbmb.2016.11.003"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-017-0394-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-017-0394-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-017-0394-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T11:07:14Z","timestamp":1570014434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-017-0394-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,14]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["394"],"URL":"https:\/\/doi.org\/10.1007\/s11914-017-0394-8","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,14]]}}}